Anticancer properties of 5Z-(4-fluorobenzylidene)-2-(4-hydroxyphenylamino)-thiazol-4-one
Open Access
- 23 July 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-16
Abstract
4-thiazolidinones, which are privileged structures in medicinal chemistry, comprise the well-known class of heterocycles and are a source of new drug-like compounds. Undoubtedly, the 5-bulky-substituted-2,4-thiazolidinediones - a class of antihyperglycemic glitazones, which are peroxisome proliferator-activated receptor gamma (PPARγ) agonists, are the most described group among them. As there are various chemically distinct 4-thiazolidinones, different subtypes have been selected for studies; however, their main pharmacological profiles are similar. The aim of this study was to evaluate the anticancer activity of 5Z-(4-fluorobenzylidene)-2-(4-hydroxyphenylamino)-thiazol-4-one (Les-236) in four human cancer cell lines, A549, SCC-15, SH-SY5Y, and CACO-2, and investigate its impact on the production of reactive oxygen species (ROS) and the apoptotic process as well as cytotoxicity and metabolism in these cell lines. The cell lines were exposed to increasing concentrations (1 nM to 100 µM) of the studied compound for 6, 24, and 48 h, and later, ROS production, cell viability, caspase-3 activity, and cell metabolism were examined. The obtained results showed that the studied compound decreased the production of ROS, increased the release of lactate dehydrogenase, and decreased cell metabolism/proliferation in all the five cell lines at micromolar concentrations. Interestingly, over a wide range of concentrations (from 1 nM to 100 µM), Les-236 was able to increase the activity of caspase-3 in BJ (after 6 h of exposure), A549, CACO-2, and SCC-15 (after 48 h of exposure) cell lines which could be an effect of the activation of PPARγ-dependent pathways.Keywords
This publication has 63 references indexed in Scilit:
- A Facile Synthesis and Anticancer Activity Evaluation of Spiro[Thiazolidinone-Isatin] ConjugatesScientia Pharmaceutica, 2011
- Synthesis of 5-arylidene-2-amino-4-azolones and evaluation of their anticancer activityBioorganic & Medicinal Chemistry, 2010
- PPARγ-independent antitumor effects of thiazolidinedionesCancer Letters, 2009
- PPAR‐γAgonists and Their Effects on IGF‐I Receptor Signaling: Implications for CancerPPAR Research, 2009
- Modulation of cell growth and PPARγ expression in human colorectal cancer cell lines by ciglitazoneExperimental and Toxicologic Pathology, 2008
- PPARγ and Apoptosis in CancerPPAR Research, 2008
- A Role for the PPARγ in Cancer TherapyPPAR Research, 2008
- Apoptosis: A Review of Programmed Cell DeathToxicologic Pathology, 2007
- Differential effects of PPARγ agonists on the metabolic properties of gliomas and astrocytesNeuroscience Letters, 2007
- Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonistsThe Lancet Oncology, 2004